Literature DB >> 12554149

Determination of serum thyroxine enantiomers in patients by liquid chromatography with a chiral mobile phase.

Rong Wang1, Zheng-Ping Jia, Xiao-Li Hu, Li-Ting Xu, Yong-Min Li, Li-Ren Chen.   

Abstract

A chromatographic method for the separation and determination of D- and L-thyroxine enantiomers (D-, and L-T4) in human serum with a chiral ligand ion-exchange system using a chiral mobile phase additive and a silica column was established. An aqueous eluent containing L-proline (L-pro) sufficiently complexed copper II ions and triethylamine (TEA) was used. It was monitored with a UV detector. The separation was completed in 12 min. The method has acceptable sensitivity, precision and accuracy for analysis. The limit of detection and the limit of quantitation for both D- and L-T4 were 0.1 microg/ml and 0.8 microg/ml, respectively. Calibration curves were linear within 1-100 microg/ml; the mean correlation coefficients were r(D-T4)=0.9986 for D-T4 and r(L-T4)=0.9978 for L-T4. T4 enantiomers were separated on baseline under the optimum condition. L-T4 eluted before D-T4. The concentration of D-T4 and L-T4 in 45 thyroid patients serum (hyperthyroid, hypothyroid, thyroidectomy, goitre or thyroiditis) using HPLC was determined, those results showed that D,L-T4 concentration varied in different thyroid patient. Attention should be paid to this result in treating thyroid disease in the clinic. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554149     DOI: 10.1016/s1570-0232(02)00959-5

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Upconversion luminescence-based aptasensor for the detection of thyroid-stimulating hormone in serum.

Authors:  Jingrong Liu; Chunxiao Yu; Luodan Han; Yiping Shen; Yao Fang; Yaokun Xia; Xu Yao; Fang Wu; Chunyan Li; Jinghua Chen; Xi Zhang; Jianming Lan
Journal:  Mikrochim Acta       Date:  2022-04-07       Impact factor: 5.833

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.